Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Ebola-Infected Doctor Is ‘Growing Stronger Every Day’

Dr. Kent Brantly completed his four-year residency in family medicine, with one year of child and maternal health, at JPS Health Network in Fort Worth, in June 2013, and left for Liberia the same month, said J.R. Labbe, a system spokeswoman. Source: John Peter Smith Hospital via Bloomberg
Dr. Kent Brantly completed his four-year residency in family medicine, with one year of child and maternal health, at JPS Health Network in Fort Worth, in June 2013, and left for Liberia the same month, said J.R. Labbe, a system spokeswoman. Source: John Peter Smith Hospital via Bloomberg

Aug. 9 (Bloomberg) -- Kent Brantly, the missionary doctor infected with Ebola who was recently returned to the U.S. for treatment in Atlanta, said he is “growing stronger every day.”

“I am writing this update from my isolation room at Emory University Hospital, where doctors and nurses are providing the very best care possible,” Brantly said in a statement released yesterday by Samaritan’s Purse, the aid group he works with.

Brantly and Nancy Writebol, an aid worker also being treated at Emory, were infected while working with patients in an Ebola center in Liberia. Family and supporters have said that Writebol too is improving, though she remains weakened.

“My focus, however, remains the same -- to follow God,” Brantly wrote. “Please pray for our recovery.”

While both Americans received an experimental treatment developed by San Diego-based Mapp Biopharmaceutical Inc., it remains unclear if they were helped by the drug. More than 40 percent of people infected by the virus have survived in the current outbreak, probably because of early medical care, health officials say.

Palmer Holt, a spokesman for SIM USA, the aid group that Writebol works with, did not immediately respond to a call and e-mail asking about her condition.

The Ebola outbreak has sickened 1,779 people and killed 961 in four Western African nations since March, according to the World Health Organization.

There is no cure for Ebola, which is spread through direct contact with body fluids, such as blood. The virus can cause bleeding from the eyes, ears, and nose. Normally, patients are given fluids, blood transfusions and antibiotics with the hope that their immune systems can fight off the infection.

The use of Mapp’s experimental antibody cocktail, called ZMapp, has raised hopes that the medicine, which has never been tested in humans before, may help treat the disease.

To contact the reporter on this story: Caroline Chen in New York at cchen509@bloomberg.net

To contact the editors responsible for this story: Reg Gale at rgale5@bloomberg.net Drew Armstrong

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.